1. Home
  2. CYTO vs XYLO Comparison

CYTO vs XYLO Comparison

Compare CYTO & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTO
  • XYLO
  • Stock Information
  • Founded
  • CYTO 2003
  • XYLO 1999
  • Country
  • CYTO Bermuda
  • XYLO Israel
  • Employees
  • CYTO N/A
  • XYLO N/A
  • Industry
  • CYTO Biotechnology: Pharmaceutical Preparations
  • XYLO
  • Sector
  • CYTO Health Care
  • XYLO
  • Exchange
  • CYTO Nasdaq
  • XYLO NYSE
  • Market Cap
  • CYTO 2.2M
  • XYLO 2.2M
  • IPO Year
  • CYTO N/A
  • XYLO N/A
  • Fundamental
  • Price
  • CYTO $0.46
  • XYLO $2.92
  • Analyst Decision
  • CYTO
  • XYLO
  • Analyst Count
  • CYTO 0
  • XYLO 0
  • Target Price
  • CYTO N/A
  • XYLO N/A
  • AVG Volume (30 Days)
  • CYTO 106.0K
  • XYLO 21.9K
  • Earning Date
  • CYTO 09-24-2024
  • XYLO 11-29-2024
  • Dividend Yield
  • CYTO N/A
  • XYLO N/A
  • EPS Growth
  • CYTO N/A
  • XYLO N/A
  • EPS
  • CYTO N/A
  • XYLO N/A
  • Revenue
  • CYTO N/A
  • XYLO $57,642,000.00
  • Revenue This Year
  • CYTO N/A
  • XYLO N/A
  • Revenue Next Year
  • CYTO N/A
  • XYLO N/A
  • P/E Ratio
  • CYTO N/A
  • XYLO N/A
  • Revenue Growth
  • CYTO N/A
  • XYLO N/A
  • 52 Week Low
  • CYTO $0.40
  • XYLO $2.70
  • 52 Week High
  • CYTO $17.20
  • XYLO $10.43
  • Technical
  • Relative Strength Index (RSI)
  • CYTO 35.16
  • XYLO 41.43
  • Support Level
  • CYTO $0.40
  • XYLO $2.71
  • Resistance Level
  • CYTO $0.62
  • XYLO $3.13
  • Average True Range (ATR)
  • CYTO 0.06
  • XYLO 0.33
  • MACD
  • CYTO 0.00
  • XYLO -0.06
  • Stochastic Oscillator
  • CYTO 25.18
  • XYLO 16.56

About CYTO Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Share on Social Networks: